Skip to main content
LOGIN REGISTER

Effect of Bifidobacterium longum 35624™ (TM) on irritable bowel syndrome severity and quality of life. Results of the Floravie observational study. With Prof Jean-Marc Sabate

In this webinar on demand, Professor Sabaté guides viewers through his latest research looking at the effect of probiotics on Quality of Life and Symptom Severity in patients with IBS. A reflective learning guide is available for you to complete after watching. The recording is from an online event hosted by the British Society of Gastroenterology on 11th November 2021.

Learning Objectives:

Understand how symptom severity is measured in those with IBS according to Rome IV criteria
Understand the impact of Bifidobacterium longum 35624® on quality of life in those with IBS
Understand how stool transit is changed with the introduction and continued use of probiotics
Understand the role of probiotics as potential therapeutic strategy for improving quality of life and symptom severity in patients with IBS

Recommended for you…

We use cookies to ensure that we give you the best experience on our website. Please confirm you are happy to continue.